Related Experiment Video
Updated: May 4, 2026
08:39
A Murine Model of Hemodialysis Access-Related Hand Dysfunction
Published on: May 31, 2022
1.8K
[Hemodialysis improves the subendocardial viability ratio]
Summary
Dialysis improves cardiovascular health by reducing pulse wave velocity (PWV) and increasing the subendocardial viability ratio (SEVR). Vascular calcification severity impacts these improvements, suggesting tailored dialysis strategies may be needed.
Area of Science:
- Cardiovascular Physiology
- Nephrology
- Biomedical Engineering
Context:
- The subendocardial viability ratio (SEVR) is a non-invasive measure of myocardial perfusion linked to left ventricular workload.
- Dialysis patients often exhibit cardiovascular complications, including elevated vascular stiffness.
Purpose:
- To investigate the impact of dialysis on SEVR and pulse wave velocity (PWV).
- To assess how SEVR and PWV changes are modulated during the interdialytic period.
- To explore the influence of vascular calcification on these parameters.
Summary:
- This study evaluated 54 dialysis patients, measuring SEVR and PWV before and after dialysis sessions.
- Results indicate that dialysis significantly reduces PWV (16% mean reduction) and increases SEVR (13% mean increase).
- Patients with severe vascular calcifications showed higher PWV and lower SEVR, with less improvement post-dialysis.
Impact:
- Ultrafiltration during dialysis effectively improves vascular stiffness and myocardial perfusion.
- The findings highlight the role of vascular calcification in modulating treatment response.
- Further research is warranted to optimize dialysis strategies for patients with high PWV and low SEVR, potentially improving outcomes given the association of high SEVR with mortality.
More Related Videos
04:36Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
Published on: October 2, 2020
2.3K
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10.2K
Related Concept Videos
01:25Hemodialysis I: Introduction
4.0K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
4.0K
01:24Hemodialysis II: Procedure and Complications
2.2K
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
2.2K
01:25Hemodialysis III: Nursing Management
1.8K
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.8K
01:30Heart Failure V: Medical Management
626
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
626
01:30Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
01:22Heart Failure VI: Adjunct Therapies
632
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632